{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T23:40:51Z","timestamp":1722037251085},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T00:00:00Z","timestamp":1447632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0142698","type":"journal-article","created":{"date-parts":[[2015,11,16]],"date-time":"2015-11-16T22:39:39Z","timestamp":1447713579000},"page":"e0142698","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of Variants of Hepatitis C Virus (HCV) Entry Factors in Patients Highly Exposed to HCV but Remaining Uninfected: An ANRS Case-Control Study"],"prefix":"10.1371","volume":"10","author":[{"given":"Baptiste","family":"Fouquet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jade","family":"Ghosn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Quertainmont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Rioux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudine","family":"Duvivier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Delfraissy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micheline","family":"Misrahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,11,16]]},"reference":[{"issue":"11","key":"ref1","first-page":"1473","article-title":"HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications","volume":"16","author":"M Andreoni","year":"2012","journal-title":"European review for medical and pharmacological sciences"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.antiviral.2009.10.021","article-title":"Viral hepatitis and HIV co-infection","volume":"85","author":"V Soriano","year":"2010","journal-title":"Antiviral Res"},{"issue":"22","key":"ref3","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.22.18888-en","article-title":"Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004","volume":"13","author":"C Larsen","year":"2008","journal-title":"Euro Surveill"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3390\/v2030692","article-title":"Recent advances in hepatitis C virus cell entry","volume":"2","author":"B Bartosch","year":"2010","journal-title":"Viruses"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.chom.2014.10.009","article-title":"The impact of hepatitis C virus entry on viral tropism","volume":"16","author":"Q Ding","year":"2014","journal-title":"Cell host & microbe"},{"issue":"42","key":"ref6","doi-asserted-by":"crossref","first-page":"41003","DOI":"10.1074\/jbc.M302267200","article-title":"Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate","volume":"278","author":"H Barth","year":"2003","journal-title":"The Journal of biological chemistry"},{"issue":"5390","key":"ref7","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"P Pileri","year":"1998","journal-title":"Science"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/v6020875","article-title":"CD81-receptor associations\u2014impact for hepatitis C virus entry and antiviral therapies","volume":"6","author":"L Zona","year":"2014","journal-title":"Viruses"},{"issue":"19","key":"ref9","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"E Scarselli","year":"2002","journal-title":"Embo J"},{"issue":"7137","key":"ref10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"MJ Evans","year":"2007","journal-title":"Nature"},{"issue":"22","key":"ref11","doi-asserted-by":"crossref","first-page":"12465","DOI":"10.1128\/JVI.01457-07","article-title":"Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus","volume":"81","author":"A Zheng","year":"2007","journal-title":"J Virol"},{"issue":"7231","key":"ref12","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells","volume":"457","author":"A Ploss","year":"2009","journal-title":"Nature"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nm.2581","article-title":"Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor","volume":"18","author":"B Sainz Jr.","year":"2012","journal-title":"Nat Med"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy","volume":"17","author":"J Lupberger","year":"2011","journal-title":"Nat Med"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2010.10.014","article-title":"Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies","volume":"54","author":"MB Zeisel","year":"2011","journal-title":"Journal of hepatology"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.21959","article-title":"Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies","volume":"47","author":"JM Timpe","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1128\/JVI.01504-09","article-title":"Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line","volume":"84","author":"S Haid","year":"2010","journal-title":"J Virol"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jmv.24088","article-title":"Claudin-1 gene variants and susceptibility to hepatitis C infection in HIV-1 infected intravenous drug users (an ANRS case-control study)","volume":"87","author":"J Ghosn","year":"2015","journal-title":"Journal of medical virology"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.meegid.2012.07.010","article-title":"Hepatitis C virus entry: role of host and viral factors","volume":"12","author":"B Samreen","year":"2012","journal-title":"Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/rmv.723","article-title":"Hepatitis C virus entry: beyond receptors","volume":"22","author":"LW Meredith","year":"2012","journal-title":"Reviews in medical virology"},{"issue":"6","key":"ref21","first-page":"933","article-title":"Hepatitis C virus entry into the hepatocyte","volume":"6","author":"S Belouzard","year":"2011","journal-title":"Cent Eur J Biol"},{"issue":"22","key":"ref22","doi-asserted-by":"crossref","first-page":"11331","DOI":"10.1128\/JVI.00104-06","article-title":"Diverse CD81 proteins support hepatitis C virus infection","volume":"80","author":"M Flint","year":"2006","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1471-2334-10-303","article-title":"The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006\u20132010","volume":"10","author":"MA Loko","year":"2010","journal-title":"BMC infectious diseases"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2893.2009.01166.x","article-title":"Genetic variation in CLDN1 and susceptibility to hepatitis C virus infection","volume":"17","author":"V Bekker","year":"2010","journal-title":"J Viral Hepat"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1155\/2012\/147148","article-title":"Chemokines and chemokine receptors in susceptibility to HIV-1 infection and progression to AIDS","volume":"32","author":"A Chatterjee","year":"2012","journal-title":"Disease markers"},{"issue":"1","key":"ref26","first-page":"30","article-title":"Host factors involved in low susceptibility to HIV infection","volume":"13","author":"C Restrepo","year":"2011","journal-title":"AIDS reviews"},{"issue":"7","key":"ref27","doi-asserted-by":"crossref","first-page":"e1003515","DOI":"10.1371\/journal.ppat.1003515","article-title":"Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls","volume":"9","author":"PJ McLaren","year":"2013","journal-title":"PLoS pathogens"},{"issue":"17","key":"ref28","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1097\/00002030-200411190-00004","article-title":"New CCR5 variants associated with reduced HIV coreceptor function in southeast Asia","volume":"18","author":"C Capoulade-Metay","year":"2004","journal-title":"Aids"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.meegid.2009.03.007","article-title":"Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil","volume":"9","author":"SL Teixeira","year":"2009","journal-title":"Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/1756-0500-6-288","article-title":"Distribution of CCR5-Delta32, CCR5 promoter 59029 A\/G, CCR2-64I and SDF1-3'A genetic polymorphisms in HIV-1 infected and uninfected patients in the west region of Cameroon","volume":"6","author":"CN Nkenfou","year":"2013","journal-title":"BMC research notes"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3329\/jhpn.v28i2.4882","article-title":"HIV infection and host genetic mutation among injecting drug-users of northeastern states of India","volume":"28","author":"K Sarkar","year":"2010","journal-title":"Journal of health, population, and nutrition"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00126334-200302010-00002","article-title":"Population survey of CCR5 delta32, CCR5 m303, CCR2b 64I, and SDF1 3'A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups","volume":"32","author":"FS Wang","year":"2003","journal-title":"Journal of acquired immune deficiency syndromes"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1089\/aid.2009.0066","article-title":"Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population","volume":"25","author":"AH Salem","year":"2009","journal-title":"AIDS research and human retroviruses"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1086\/302568","article-title":"Distribution of two HIV-1-resistant polymorphisms (SDF1-3'A and CCR2-64I) in East Asian and world populations and its implication in AIDS epidemiology","volume":"65","author":"B Su","year":"1999","journal-title":"American journal of human genetics"},{"issue":"18","key":"ref35","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1097\/00002030-200212060-00016","article-title":"Polymorphisms of CCR5 gene in a southern Chinese population and their effects on disease progression in HIV infections","volume":"16","author":"BJ Zheng","year":"2002","journal-title":"Aids"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00002030-200003310-00003","article-title":"Global distribution of the CCR2-64I\/CCR5-59653T HIV-1 disease-protective haplotype","volume":"14","author":"JJ Martinson","year":"2000","journal-title":"Aids"},{"issue":"5283","key":"ref37","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1126\/science.273.5283.1856","article-title":"Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study","volume":"273","author":"M Dean","year":"1996","journal-title":"Science"},{"issue":"6593","key":"ref38","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/382722a0","article-title":"Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene","volume":"382","author":"M Samson","year":"1996","journal-title":"Nature"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1089\/aid.2011.0362","article-title":"Protective effect of CCR5-Delta32 against HIV infection by the heterosexual mode of transmission in a Polish population","volume":"29","author":"K Zwolinska","year":"2013","journal-title":"AIDS research and human retroviruses"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00126334-200108150-00009","article-title":"Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection","volume":"27","author":"M Marmor","year":"2001","journal-title":"Journal of acquired immune deficiency syndromes"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/aid.2006.0113","article-title":"High prevalence of the CCR5Delta32 HIV-resistance mutation among Estonian HIV type 1-infected individuals","volume":"23","author":"M Adojaan","year":"2007","journal-title":"AIDS research and human retroviruses"},{"issue":"5328","key":"ref42","first-page":"959","article-title":"Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study","volume":"277","author":"MW Smith","year":"1997","journal-title":"Science"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s004390050726","article-title":"Mutational analysis of the CCR5 and CXCR4 genes (HIV-1 co-receptors) in resistance to HIV-1 infection and AIDS development among intravenous drug users","volume":"102","author":"V Alvarez","year":"1998","journal-title":"Human genetics"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.meegid.2014.03.009","article-title":"Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection","volume":"24","author":"H Li","year":"2014","journal-title":"Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/650491","article-title":"CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users","volume":"201","author":"K Huik","year":"2010","journal-title":"The Journal of infectious diseases"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0142698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T07:52:34Z","timestamp":1653551554000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0142698"}},"subtitle":[],"editor":[{"given":"Tony","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,16]]},"references-count":45,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0142698","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,16]]}}}